Zymeworks (ZYME) Change in Acquisitions & Divestments (2022 - 2026)
Zymeworks (ZYME) posted Change in Acquisitions & Divestments of $70.2 million for Q1 2026, up 11.54% sequentially from $62.9 million in Q4 2025, and up 50.75% YoY from $46.6 million in Q1 2025.
Analysis
Zymeworks (ZYME) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends
Zymeworks has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $70.2 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments rose 50.75% year-over-year to $70.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $248.7 million (down 20.36% YoY) and the FY2025 annual result came in at $225.1 million, down 30.87% from the prior year.
- Change in Acquisitions & Divestments climbed to $70.2 million in Q1 2026 per ZYME's latest filing, from $62.9 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $125.9 million in Q3 2024 and troughed at -$46.2 million in Q4 2022.
- A 5-year average of $64.5 million and a median of $62.3 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments jumped 234.96% in 2023, then sank 71.55% in 2025.
- Over 5 years, Change in Acquisitions & Divestments stood at -$46.2 million in 2022, then surged by 234.96% to $62.3 million in 2023, then slipped by 23.11% to $47.9 million in 2024, then jumped by 31.29% to $62.9 million in 2025, then advanced by 11.54% to $70.2 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $70.2 million, $62.9 million, and $35.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Zymeworks | 2.13 Bn | 1.86 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.61 Mn |
| Mar 31, 2026 | 70.18 Mn |
| Dec 31, 2025 | 62.92 Mn |
| Sep 30, 2025 | 35.83 Mn |
| Jun 30, 2025 | 79.78 Mn |
| Mar 31, 2025 | 46.55 Mn |
| Dec 31, 2024 | 47.92 Mn |
| Sep 30, 2024 | 125.95 Mn |
| Jun 30, 2024 | 91.85 Mn |
| Mar 31, 2024 | 59.85 Mn |
| Dec 31, 2023 | 62.33 Mn |
| Sep 30, 2023 | 119.20 Mn |
| Jun 30, 2023 | 124.33 Mn |
| Mar 31, 2023 | 44.22 Mn |
| Dec 31, 2022 | -46.18 Mn |
| Sep 30, 2022 | 43.14 Mn |